HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of systemic lupus erythematosus with low serum bilirubin levels.

AbstractOBJECTIVE:
Systemic lupus erythematosus (SLE) is accompanied by severe oxidative stress. Bilirubin has been reported as a strong negative predictor of oxidative stress-mediated diseases, such as atherosclerosis. The objective of our study was to evaluate the association between serum bilirubin levels and SLE manifestation.
METHODS:
The study was performed with 259 SLE patients, diagnosed according to American Rheumatism Association (ARA) criteria. A subset of these patients, having normal hepatic function (n = 218, mean age 39.5 years), was studied in greater detail to eliminate the possible confounding effects of any underlying or drug-induced liver disease on the serum bilirubin levels. Age-matched healthy subjects (n = 180) served as the control group. A standard biochemical and immunological work-up was performed on all subjects.
RESULTS:
Compared to the controls, substantially lower levels of serum bilirubin were detected in SLE patients (p < 10⁻⁵); these were inversely correlated with disease activity and extent (p < 0.05). Furthermore, each 1 μmol/L decrease in serum bilirubin was associated with a 37% increase in the odds for a positive SLE status [odds ratio (OR) 1.37, 95% confidence interval (CI) 1.28-1.47, p < 10⁻⁵]. Simultaneously, the odds of unconjugated hyperbilirubinaemia (a phenotypic sign of Gilbert's syndrome) were more than four times lower in SLE patients (OR 0.235, 95% CI 0.072-0.764, p = 0.016).
CONCLUSION:
Low serum bilirubin represented a strong predictor of the manifestation of SLE symptoms. The most likely explanation for this finding is the increased consumption of bilirubin due to the severe oxidative stress accompanying SLE. Subjects with higher serum bilirubin levels, such as those with Gilbert's syndrome, might be protected from the development of SLE.
AuthorsL Vítek, L Muchová, E Jančová, S Pešičková, D Tegzová, V Peterová, K Pavelka, V Tesař, Ha Schwertner
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 39 Issue 6 Pg. 480-4 (Nov 2010) ISSN: 1502-7732 [Electronic] England
PMID20604673 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bilirubin
Topics
  • Adult
  • Bilirubin (blood)
  • Case-Control Studies
  • Female
  • Gilbert Disease (blood, diagnosis)
  • Humans
  • Liver Diseases (blood, diagnosis)
  • Lupus Erythematosus, Systemic (blood, diagnosis)
  • Male
  • Middle Aged
  • Oxidative Stress
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: